Moosazadeh Mahmood, Esmaeili Ravanbakhsh, Mehdi Nasehi Mohammad, Abedi Ghasem, Afshari Mahdi, Farshidi Fereshteh, Kheradmand Motahareh
Health Sciences Research Center, School of Health, Mazandaran University of Medical Sciences, Sari, Iran.
Department of Medical-Surgical Nursing, Nasibeh School of Nursing and Midwifery, Mazandaran University of Medical Sciences, Sari, Iran.
Iran J Neurol. 2017 Apr 4;16(2):90-95.
Familial history of multiple sclerosis (MS) has been considered as one of the etiologic factors of MS by several studies. It is valuable to combine the results of these studies. The aim of this study is to estimate the pooled prevalence of familial MS in Iran using meta-analysis. Using relevant keywords, national and international databanks were searched. Considering the significant heterogeneity between the results, random effect model was utilized to estimate the pooled prevalence of familial MS using Stata software. After screening the selected articles, 15 studies with total sample size of 6248 (from 60 to 1718) were identified eligible for final meta-analysis. Overall prevalence of familial MS in Iran was estimated as of 11.4% [95% confidence interval (CI): 8.7-14.1]. Point prevalence varied between 3.3% and 26.7%. Our study showed that the familial prevalence of MS among Iranian people is relatively high. More studies are warranted to investigate the effect of familial history as a risk factor for MS.
多项研究已将多发性硬化症(MS)家族史视为MS的病因之一。综合这些研究结果很有价值。本研究的目的是通过荟萃分析估计伊朗家族性MS的合并患病率。使用相关关键词检索了国内和国际数据库。考虑到结果之间存在显著异质性,利用随机效应模型,使用Stata软件估计家族性MS的合并患病率。在筛选选定的文章后,确定了15项研究符合最终荟萃分析的条件,总样本量为6248(从60到1718)。伊朗家族性MS的总体患病率估计为11.4%[95%置信区间(CI):8.7 - 14.1]。点患病率在3.3%至26.7%之间。我们的研究表明,伊朗人群中MS的家族患病率相对较高。有必要开展更多研究来调查家族史作为MS风险因素的影响。